Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 77Thoracic 2Head & Neck 2Gynecologic 2Genitourinary 1Dermatologic 1CNS 1

Conditions

Brain Neoplasms 15Central Nervous System Neoplasms 12Ovarian Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Lung Neoplasms 6Glioma 6Glioblastoma 6Testicular Neoplasms 4Testicular Germ Cell Tumor 4Astrocytoma 4Teratoma 3Squamous Cell Carcinoma of Head and Neck 3Seminoma 3Pancreatic Neoplasms 3Neoplasms 3Melanoma 3Medulloblastoma 3Lymphoma, Non-Hodgkin 3Gliosarcoma 3Endodermal Sinus Tumor 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Thyroid Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Neuroectodermal Tumors, Primitive 2

Interventions

regorafenib 2Nivolumab 2pembrolizumab 1aflibercept 1adavosertib 1Radiotherapy 1Radiation 1Paclitaxel 1NEO212 1Ipilimumab 1IFL protocol 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Paclitaxel × CNS × Clear all
NCT06047379 2026-03-02

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Neonc Technologies, Inc.

Phase 1/2 Recruiting
134 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Astrocytoma, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Central Nervous System Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡